financetom
Business
financetom
/
Business
/
BRIEF-Discovery Capital Management Reports 8.4% Passive Stake In OneMedNet Corp
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Discovery Capital Management Reports 8.4% Passive Stake In OneMedNet Corp
Aug 5, 2024 3:49 PM

Aug 5 (Reuters) -

Discovery Capital Management:

* DISCOVERY CAPITAL MANAGEMENT, LLC REPORTS 8.4% PASSIVE

STAKE IN

ONEMEDNET CORP AS OF JULY 25 - SEC FILING

Source text for Eikon:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Swedish Fintech Giant Klarna IPO Prices Above Expected Range
Swedish Fintech Giant Klarna IPO Prices Above Expected Range
Sep 10, 2025
04:59 AM EDT, 09/10/2025 (MT Newswires) -- Klarna Group ( KLAR ) said late Tuesday it priced its initial public offering of about 34.3 million shares at $40 apiece. Earlier this month, the Swedish fintech giant said it expected the IPO to be priced between $35 and $37 per share. Klarna ( KLAR ) said late Tuesday it is selling...
SageSure Agrees to Acquire Olympus MGA
SageSure Agrees to Acquire Olympus MGA
Sep 10, 2025
Acquisition accelerates SageSure’s growth into the mass-affluent homeowners segment in Florida. JERSEY CITY, N.J.--(BUSINESS WIRE)-- SageSure, one of the largest managing general underwriters focused on catastrophe-exposed markets, announced today that it has entered into a definitive agreement to acquire Gemini Financial Holdings Corporation (“Gemini Financial”) and its subsidiaries, including Olympus MGA Corp. (“Olympus MGA”). Olympus MGA, one of the...
US FDA approves J&J's bladder cancer treatment
US FDA approves J&J's bladder cancer treatment
Sep 10, 2025
By Mariam Sunny Sept 10 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's ( JNJ ) drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, branded as Inlexzo, was approved for patients with a type of high-risk non-muscle invasive bladder cancer who did not...
Capital Southwest Prices $350 Million Notes Offering
Capital Southwest Prices $350 Million Notes Offering
Sep 10, 2025
04:53 AM EDT, 09/10/2025 (MT Newswires) -- Capital Southwest ( CSWC ) said late Tuesday it has priced an underwritten public offering of $350 million worth of 5.95% notes due 2030. The notes will be issued at 99.345% of the principal amount, said the company. Capital Southwest ( CSWC ) expects to close the offering on Sept. 18. Proceeds will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved